The proposed regulations aim to allow legal and quality-controlled products to be available by July 2018 and immediately begin to address the public health and safety risks posed by illegally-produced cannabis.
Recent research from EMCDDA shows that there is no evidence to support the use of randomised drug testing for reducing drug use among those tested and among their school peers.
Thanks to the action taken by ANPUD and other organisations of people who use drugs, Apple has removed apps promoting violence, murder, and extrajudicial killings in the Philippines.
IDPC and WACD summarise and review existing drug legislation from the 15 ECOWAS member states, as well as Mauritania and Morocco, concluding on the need for reform to align domestic laws with regional and international commitments.
The EMCDDA publishes a report providing an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area.
The Guide contains practical advice on implementing HIV and hepatitis C programs with people who inject drugs and can be used by policy makers, practitioners and advocates to promote effective policy and practice.
EU Member States could learn from past experiences in legalizing cannabis for medical and non-medical purposes, and decide if they want to maintain their current cannabis supply policies or try evidence-based alternatives.
